Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ZIDOVUDINE RESISTANCE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 145 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cho, YK; Sung, H; Lee, HJ; Joo, CH; Cho, GJ
      Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Kyriakides, TC; Heimer, RR
      Development and application of a genotypic AZT resistance assay - Quantitative assessment of the resistance profile of clinical samples and the relative predictive ability of a resistance index

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Lu, J; Kuritzkes, DR
      A novel recombinant marker virus assay for comparing the relative fitness of HIV-1 reverse transcriptase variants

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Briones, C; Perez-Olmeda, M; Rodriguez, C; del Romero, J; Hertogs, K; Soriano, V
      Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Kamkamidze, G; Sullivan, T; Charbonneau, T
      Occurrence of HIV-1 reverse transcriptase gene mutation at codon 215 in HIV-infected infants

      JOURNAL OF CLINICAL VIROLOGY
    6. Vandamme, AM; Houyez, F; Banhegyi, D; Clotet, B; De Schrijver, G; De Smet, KAL; Hall, WW; Harrigan, R; Hellmann, N; Hertogs, K; Holtzer, C; Larder, B; Pillay, D; Race, E; Schmit, JC; Schuurman, R; Shulse, E; Sonnerborg, A; Miller, V
      Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up

      ANTIVIRAL THERAPY
    7. Van Vaerenbergh, K; Debaisieux, L; De Cabooter, N; Declercq, C; Desmet, K; Fransen, K; Maes, B; Marissens, D; Miller, K; Muyldermans, G; Sprecher, S; Stuyver, L; Vaira, D; Verhofstede, C; Zissis, G; Van Ranst, M; De Clercq, E; Desmyter, J; Vandamme, AM
      Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium

      ANTIVIRAL THERAPY
    8. Miller, V; Larder, BA
      Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure

      ANTIVIRAL THERAPY
    9. Sitnitskaya, Y; Rochford, G; Rigaud, M; Essajee, S; Pollack, H; Krasinski, K; Borkowsky, W
      Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995-1999

      CLINICAL INFECTIOUS DISEASES
    10. Hanna, GJ; D'Aquila, RT
      Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy

      CLINICAL INFECTIOUS DISEASES
    11. Soriano, V
      Sequencing antiretroviral drugs

      AIDS
    12. Miller, V; Vandamme, AM; Loveday, C; Staszewski, S; Lundgren, J; Youle, M; Ait-Khaled, M; Boucher, C; Brun-Vezinet, F; Dedes, N; Giaquinto, C; Hertogs, K; Houyez, F; Perrin, L; Pillay, D; Schmit, JC; Schuurman, R; Lange, J; Banhegyi, D; Biondi, G; Broekhuizen, A; Bush-Donovan, C; Camacho, R; Carlier, H; Clavel, F; Clotet, B; Clumeck, N; Colebunders, R; De Clerq, K; De Jaegher, JJ; De Schrijver, G; De Smet, K; Hall, W; Harrigan, R; Hatzakis, A; Hellmann, N; Hoetelmans, R; Holtzer, C; Katlama, C; Larder, D; Loriaux, E; McCreedy, B; Mulcahy, F; Opravil, M; Phillips, A; Ruiz, N; Shulse, E; Sonnerborg, A; Soriano, V; Steel, H; Vella, S; Williams, A
      Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting

      AIDS
    13. Menendez, MA; de Oteyza, CP
      Antirretroviral drugs resistance

      ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
    14. Erali, M; Page, S; Reimer, LG; Hillyard, DR
      Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods

      JOURNAL OF CLINICAL MICROBIOLOGY
    15. Perno, CF; Cozzi-Lepri, A; Balotta, C; Forbici, F; Violin, M; Bertoli, A; Facchi, G; Pezzotti, P; Cadeo, G; Tositti, G; Pasquinucci, S; Pauluzzi, S; Scalzini, A; Salassa, B; Vincenti, A; Phillips, AN; Dianzani, F; Appice, A; Angarano, G; Monno, L; Ippolito, G; Moroni, M; Monforte, AD
      Secondary mutations in the protease region of human immunodeficiency virusand virologic failure in drug-naive patients treated with protease inhibitor-based therapy

      JOURNAL OF INFECTIOUS DISEASES
    16. Gotte, M; Wainberg, MA
      Biochemical mechanisms involved in overcoming HIV resistance to nucleosideinhibitors of reverse transcriptase

      DRUG RESISTANCE UPDATES
    17. Fridland, A; Connelly, MC; Robbins, BL
      Cellular factors for resistance against antiretroviral agents

      ANTIVIRAL THERAPY
    18. Balotta, C; Berlusconi, A; Pan, A; Violin, M; Riva, C; Colombo, MC; Gori, A; Papagno, L; Corvasce, S; Mazzucchelli, R; Facchi, G; Velleca, R; Saporetti, G; Galli, M; Rusconi, S; Moroni, N
      Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals

      ANTIVIRAL THERAPY
    19. Little, SJ
      Transmission and prevalence of HIV resistance among treatment-naive subjects

      ANTIVIRAL THERAPY
    20. Brenner, B; Wainberg, MA; Salomon, H; Rouleau, D; Dascal, A; Spira, B; Sekaly, RP; Conway, B; Routy, JP
      Resistance to antiretroviral drugs in patients with primary HIV-1 infection

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    21. Kartsonis, NA; D'Aquila, RT
      Clinical monitoring of HIV-1 infection in the era of antiretroviral resistance testing

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    22. Van Vaerenbergh, K; Van Laethem, K; Van Wijngaerden, E; Schmit, JC; Schneider, F; Ruiz, L; Clotet, B; Verhofstede, C; Van Wanzeele, F; Muyldermans, G; Simons, P; Stuyver, L; Hermans, P; Evans, C; De Clercq, E; Desmyter, J; Vandamme, AM
      Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    23. Gilbert, PB; Hanna, GJ; De Gruttola, V; Martinez-Picado, J; Kuritzkes, DR; Johnson, VA; Richman, DD; D'Aquila, RT
      Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    24. Balotta, C; Berlusconi, A; Pan, A; Violin, M; Riva, C; Gori, A; Corvasce, S; Mazzucchelli, R; Facchi, G; Velleca, R; Senese, D; Deho, L; Galli, M; Rusconi, S; Moroni, M
      Prevalence of HIV-1 resistant strains in recent seroconverters

      JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    25. Welles, SL; Pitt, J; Colgrove, R; McIntosh, K; Chung, PH; Colson, A; Lockman, S; Fowler, MG; Hanson, C; Landesman, S; Moye, J; Rich, KC; Zorrilla, C; Japour, AJ
      HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infanttransmission in the Women and Infants Transmission Study

      AIDS
    26. Precious, HM; Gunthard, HF; Wong, JK; D'Aquila, RT; Johnson, VA; Kuritzkes, DR; Richman, DD; Brown, AJL
      Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy

      AIDS
    27. Clarke, JR; Kaye, S; Babiker, AG; Hooker, MH; Tedder, R; Weber, JN
      Comparison of a point mutation assay with a line probe assay for the detection of the major mutations in the HIV-1 reverse transcriptase gene associated with reduced susceptibility to nucleoside analogues

      JOURNAL OF VIROLOGICAL METHODS
    28. Omrani, AS; Pillay, D
      Multi-drug resistant HIV-1

      JOURNAL OF INFECTION
    29. Hirsch, MS; Brun-Vezinet, F; D'Aquila, RT; Hammer, SM; Johnson, VA; Kuritzkes, DR; Loveday, C; Mellors, JW; Clotet, B; Conway, B; Demeter, LM; Vella, S; Jacobsen, DM; Richman, DD
      Antiretroviral drug resistance testing in adult HIV-1 infection - Recommendations of an International AIDS Society-USA panel

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    30. Petropoulos, CJ; Parkin, NT; Limoli, KL; Lie, YS; Wrin, T; Huang, W; Tian, H; Smith, D; Winslow, GA; Capon, DJ; Whitcomb, JM
      A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    31. Van Rompay, KKA; Miller, MD; Marthas, ML; Margot, NA; Dailey, PJ; Canfield, DR; Tarara, RP; Cherrington, JM; Aguirre, NL; Bischofberger, N; Pedersen, NC
      Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA

      JOURNAL OF VIROLOGY
    32. Brown, AJL; Precious, HM; Whitcomb, JM; Wong, JK; Quigg, M; Huang, W; Daar, ES; D'Aquila, RT; Keiser, PH; Connick, E; Hellmann, NS; Petropoulos, CJ; Richman, DD; Little, SJ
      Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) frompatients with primary HIV infection to nonnucleoside reverse transcriptaseinhibitors is associated with variation at novel amino acid sites

      JOURNAL OF VIROLOGY
    33. Cesaire, R; Dos Santos, G; Abel, S; Bera, O; Sobesky, G; Cabie, A
      Drug resistance mutations among HIV-1 strains from antiretroviral-naive patients in Martinique, French West Indies

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    34. Sheldon, JG; Condra, JH
      Genotypic analysis methods for detection of drug resistance mutations in the HIV-1 proteinase and reverse transcriptase genes

      ANTIVIRAL THERAPY
    35. Soriano, V
      Prevalence of drug resistance mutations in Spain among both naive and pretreated patients

      ANTIVIRAL THERAPY
    36. Gianotti, N; Moretti, F; Tambussi, G; Racca, S; Presi, S; Crucianelli, R; Carrera, P; Ferrari, M; Lazzarin, A
      Study on mutations and antiretroviral therapy (SMART): preliminary results

      ANTIVIRAL THERAPY
    37. Favia, A; Di Stefano, M; Fiore, JR; Pastore, G; Angarano, G
      Phenotypic patterns of HIV-1 clonal populations during highly active antiretroviral therapy (HAART)

      MICROBIOLOGICA
    38. Moussa, M; Mognetti, B; Dubanchet, S; Menu, E; Roques, P; Gras, G; Dormont, D; Barre-Sinoussi, F; Chaouat, G
      Vertical transmission of HIV: Parameters which might affect infection of placental trophoblasts by HIV-1: A review

      AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
    39. Parekh, B; Phillips, S; Granade, TC; Baggs, J; Hu, DJ; Respess, R
      Impact of HIV type 1 subtype variation on viral RNA quantitation

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    40. Gatanaga, H; Oka, S; Ida, S; Wakabayashi, T; Shioda, T; Iwamoto, A
      Active HIV-1 redistribution and replication in the brain with HIV encephalitis

      ARCHIVES OF VIROLOGY
    41. Van de Perre, P
      Mother-to-child transmission of HIV-1: the 'all mucosal' hypothesis as a predominant mechanism of transmission

      AIDS
    42. Alexander, CS; Dong, W; Schechter, MT; O'Shaughnessy, MV; Strathdee, SA; Mo, T; Montaner, JSG; Harrigan, PR
      Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users

      AIDS
    43. Ledesma, E; Soriano, V
      Spanish consensus conference on drug resistance testing in clinical practice

      AIDS
    44. Young, B; Kuritzkes, DR
      Viral kinetics: implications for treatment

      AIDS
    45. Colgrove, R; Japour, A
      A combinatorial ledge: reverse transcriptase fidelity, total body viral burden, and the implications of multiple-drug HIV therapy for the evolution of antiviral resistance

      ANTIVIRAL RESEARCH
    46. Koch, N; Yahi, N; Colson, P; Fantini, J; Tamalet, C
      Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis

      JOURNAL OF VIROLOGICAL METHODS
    47. Puchhammer-Stockl, E; Schmied, B; Mandl, CW; Vetter, N; Heinz, FX
      Comparison of line probe assay (LIPA) and sequence analysis for detection of HIV-1 drug resistance

      JOURNAL OF MEDICAL VIROLOGY
    48. Boden, D; Hurley, A; Zhang, LQ; Cao, YZ; Guo, Y; Jones, E; Tsay, J; Ip, J; Farthing, C; Limoli, K; Parkin, N; Markowitz, M
      HIV-1 drug resistance in newly infected individuals

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    49. Little, SJ; Daar, ES; D'Aquila, RT; Keiser, PH; Connick, E; Whitcomb, JM; Hellmann, NS; Petropoulos, CJ; Sutton, L; Pitt, JA; Rosenberg, ES; Koup, RA; Walker, BD; Richman, DD
      Reduced antiretroviral drug susceptibility among patients with primary HIVinfection

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    50. Pomerantz, RJ
      Primary HIV-1 resistance - A new phase in the epidemic?

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    51. Smith, RA; Klarmann, GJ; Stray, KM; von Schwedler, UK; Schinazi, RF; Preston, BD; North, TW
      A new point mutation (P157S) in the reverse transcriptase of human immunodeficiency virus type 1 confers low-level resistance to (-)-beta-2 ',3 '-dideoxy-3 '-thiacytidine

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    52. Kosalaraksa, P; Kavlick, MF; Maroun, V; Le, R; Mitsuya, H
      Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an in vitro competitive HIV-1 replication assay

      JOURNAL OF VIROLOGY
    53. Martinez-Picado, J; Savara, LV; Sutton, L; D'Aquila, RT
      Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1

      JOURNAL OF VIROLOGY
    54. Sharma, PL; Crumpacker, CS
      Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val

      JOURNAL OF VIROLOGY
    55. Kully, C; Yerly, S; Erb, P; Kind, C; Krautheim, A; Perrin, L; Rudin, C
      Codon 215 mutations in human immunodeficiency virus-infected pregnant women

      JOURNAL OF INFECTIOUS DISEASES
    56. Miller, MD; Anton, KE; Mulato, AS; Lamy, PD; Cherrington, JM
      Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro

      JOURNAL OF INFECTIOUS DISEASES
    57. Grassly, NC; Harvey, PH; Holmes, EC
      Population dynamics of HIV-1 inferred from gene sequences

      GENETICS
    58. Vandamme, AM; Van Laethem, K; De Clercq, E
      Managing resistance to anti-HIV drugs - An important consideration for effective disease management

      DRUGS
    59. Zolopa, AR; Shafer, RW; Warford, A; Montoya, JG; Hsu, P; Katzenstein, D; Merigan, TC; Efron, B
      HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed

      ANNALS OF INTERNAL MEDICINE
    60. WAINBERG MA; CAMERON DW
      HIV RESISTANCE TO ANTIVIRAL DRUGS - PUBLIC-HEALTH IMPLICATIONS

      DRUG RESISTANCE UPDATES
    61. VONSEIDLEIN L; PLAEGER S; DICKOVER R; KROGSTAD P; STIEHM ER; BRYSON Y
      PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION DURING PREGNANCY-ASSOCIATED WITH TRANSMISSION OF SI MT-2 CELL TROPIC VIRUS AND PRECIPITOUS LOSS OF CD4 CELLS IN MOTHER AND INFANT/

      The Pediatric infectious disease journal
    62. TACHEDJIAN G; MELLORS JW; BAZMI H; MILLS J
      IMPAIRED FITNESS OF FOSCARNET-RESISTANT STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      AIDS research and human retroviruses
    63. GUNTHARD HF; WONG JK; IGNACIO CC; HAVLIR DV; RICHMAN DD
      COMPARATIVE PERFORMANCE OF HIGH-DENSITY OLIGONUCLEOTIDE SEQUENCING AND DIDEOXYNUCLEOTIDE SEQUENCING OF HIV TYPE-1 POL FROM CLINICAL-SAMPLES

      AIDS research and human retroviruses
    64. FRIEDMAN SR; WAINBERG MA; DRUCKER E
      THERAPEUTIC ETHICS AND COMMUNITIES AT RISK IN THE PRESENCE OF POTENTIAL MUTATION TO RESISTANT STRAINS TO HIV ANTIVIRAL MEDICATIONS

      AIDS
    65. BRATT G; KARLSSON A; LEANDERSSON AC; ALBERT J; WAHREN B; SANDSTROM E
      TREATMENT HISTORY AND BASE-LINE VIRAL LOAD, BUT NOT VIRAL TROPISM OR CCR-5 GENOTYPE, INFLUENCE PROLONGED ANTIVIRAL EFFICACY OF HIGHLY-ACTIVE ANTIRETROVIRAL TREATMENT

      AIDS
    66. RAFFI F; RELIQUET V; AUGER S; BESNIER JM; CHENNEBAULT JM; BILLAUD E; MICHELET C; PERRE P; LAFEUILLADE A; MAY T; BILLAUDEL S
      EFFICACY AND SAFETY OF STAVUDINE AND DIDANOSINE COMBINATION THERAPY IN ANTIRETROVIRAL-EXPERIENCED PATIENTS

      AIDS
    67. REICHELDERFER PS; COOMBS RW
      CARTESIAN COORDINATE ANALYSIS OF VIRAL BURDEN AND CD4-CELL COUNT IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION( T)

      Antiviral research
    68. WAINBERG MA; FRIEDLAND G
      PUBLIC-HEALTH IMPLICATIONS OF ANTIRETROVIRAL THERAPY AND HIV DRUG-RESISTANCE

      JAMA, the journal of the American Medical Association
    69. HIRSCH MS; CONWAY B; DAQUILA RT; JOHNSON VA; BRUNVEZINET F; CLOTET B; DEMETER LM; HAMMER SM; JACOBSEN DM; KURITZKES DR; LOVEDAY C; MELLORS JW; VELLA S; RICHMAN DD
      ANTIRETROVIRAL DRUG-RESISTANCE TESTING IN ADULTS WITH HIV-INFECTION -IMPLICATIONS FOR CLINICAL MANAGEMENT

      JAMA, the journal of the American Medical Association
    70. DESCAMPS D; CALVEZ V; COLLIN G; CECILLE A; APETREI C; DAMOND F; KATLAMA C; MATHERON S; HURAUX JM; BRUNVEZINET F
      LINE PROBE ASSAY FOR DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1MUTATIONS CONFERRING RESISTANCE TO NUCLEOSIDE INHIBITORS OF REVERSE-TRANSCRIPTASE - COMPARISON WITH SEQUENCE-ANALYSIS

      Journal of clinical microbiology
    71. MCSHARRY JJ; LURAIN NS; DRUSANO GL; LANDAY AL; NOTKA M; OGORMAN MRG; WEINBERG A; SHAPIRO HM; REICHELDERFER PS; CRUMPACKER CS
      RAPID GANCICLOVIR SUSCEPTIBILITY ASSAY USING FLOW-CYTOMETRY FOR HUMANCYTOMEGALOVIRUS CLINICAL ISOLATES

      Antimicrobial agents and chemotherapy
    72. MULATO AS; LAMY PD; MILLER MD; LI WX; ANTON KE; HELLMANN NS; CHERRINGTON JM
      GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS ISOLATED FROM AIDS PATIENTS AFTER PROLONGED ADEFOVIR DIPIVOXIL THERAPY

      Antimicrobial agents and chemotherapy
    73. Zaric, GS; Bayoumi, AM; Brandeau, ML; Owens, DK
      The effects of protease inhibitors on the spread of HIV and the development of drug-resistant HIV strains: A simulation study

      SIMULATION
    74. EASTMAN PS; MITTLER J; KELSO R; GEE C; BOYER E; KOLBERG J; URDEA M; LEONARD JM; NORBECK DW; MO HM; MARKOWITZ M
      GENOTYPIC CHANGES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ASSOCIATED WITH LOSS OF SUPPRESSION OF PLASMA VIRAL-RNA LEVELS IN SUBJECTS TREATEDWITH RITONAVIR (NORVIR) MONOTHERAPY

      Journal of virology
    75. VIANI RM; SMITH IL; SPECTOR SA
      HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PHENOTYPES IN CHILDREN WITH ADVANCED DISEASE TREATED WITH LONG-TERM ZALCITABINE

      The Journal of infectious diseases
    76. FISCUS SA; HUGHES MD; LATHEY JL; PI T; JACKSON JB; RASHEED S; ELBEIK T; REICHMAN R; JAPOUR A; BYINGTON R; SCOTT W; GRIFFITH BP; KATZENSTEIN DA; HAMMER SM
      CHANGES IN VIROLOGICAL MARKERS AS PREDICTORS OF CD4 CELL DECLINE AND PROGRESSION OF DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTEDADULTS TREATED WITH NUCLEOSIDES

      The Journal of infectious diseases
    77. MOYLE GJ; GAZZARD BG; COOPER DA; GATELL J
      ANTIRETROVIRAL THERAPY FOR HIV-INFECTION - A KNOWLEDGE-BASED APPROACHTO DRUG SELECTION AND USE

      Drugs
    78. ARION D; KAUSHIK N; MCCORMICK S; BORKOW G; PARNIAK MA
      PHENOTYPIC MECHANISM OF HIV-1 RESISTANCE TO 3'-AZIDO-3'-DEOXYTHYMIDINE (AZT) - INCREASED POLYMERIZATION PROCESSIVITY AND ENHANCED SENSITIVITY TO PYROPHOSPHATE OF THE MUTANT VIRAL REVERSE-TRANSCRIPTASE

      Biochemistry (Easton)
    79. PAZZANI MJ; SEE D; SCHROEDER E; TILLE J
      APPLICATION OF AN EXPERT-SYSTEM IN THE MANAGEMENT OF HIV-INFECTED PATIENTS

      Journal of acquired immune deficiency syndromes and human retrovirology
    80. SINICCO A; FORA R; RAITERI R; SCIANDRA M; BECHIS G; CALVO MM; GIOANNINI P
      IS THE CLINICAL COURSE OF HIV-INFECTION CHANGING - REPLY

      BMJ. British medical journal
    81. SAKAMOTO T; WAKAMIYA N; TOCHIKURA A; TSUCHIE H; KURIMURA T
      DIFFERENCE OF VIRUS POPULATIONS IN HIV CARRIERS IN RELATION TO AZT TREATMENT

      International journal of STD & AIDS
    82. SCHUURMAN R
      STATE-OF-THE-ART OF GENOTYPIC HIV-1 DRUG-RESISTANCE

      Current opinion in infectious diseases
    83. MELLADO MJ; CILLERUELO MJ; ORTIZ M; VILLOTA J; GARCIA M; PEREZJURADO ML; BARREIRO G; MARTINFONTELOS P; BERNAL A
      VIRAL PHENOTYPE, ANTIRETROVIRAL RESISTANCE AND CLINICAL EVOLUTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN

      The Pediatric infectious disease journal
    84. MCINTOSH K
      ANTIRETROVIRAL RESISTANCE AND HIV VERTICAL TRANSMISSION

      Acta paediatrica
    85. GROSCHEL B; CINATL J; CINATL J
      VIRAL AND CELLULAR FACTORS FOR RESISTANCE AGAINST ANTIRETROVIRAL AGENTS

      Intervirology
    86. CRAIG C; MOYLE G
      THE DEVELOPMENT OF RESISTANCE OF HIV-1 TO ZALCITABINE

      AIDS
    87. ERCOLI L; SARMATI L; NICASTRI E; GIANNINI G; GALLUZZO C; VELLA S; ANDREONI M
      HIV PHENOTYPE SWITCHING DURING ANTIRETROVIRAL THERAPY - EMERGENCE OF SAQUINAVIR-RESISTANT STRAINS WITH LESS CYTOPATHOGENICITY

      AIDS
    88. ABOBO CV; XIAN YM
      LACK OF PHARMACOKINETIC INTERACTION BETWEEN DIPYRIDAMOLE AND ZALCITABINE IN RATS

      Cellular and molecular biology
    89. WINTERS MA; SHAFER RW; JELLINGER RA; MAMTORA G; GINGERAS T; MERIGAN TC
      HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE GENOTYPE AND DRUG SUSCEPTIBILITY CHANGES IN INFECTED INDIVIDUALS RECEIVING DIDEOXYINOSINE MONOTHERAPY FOR 1 TO 2 YEARS

      Antimicrobial agents and chemotherapy
    90. STUYVER L; WYSEUR A; ROMBOUT A; LOUWAGIE J; SCARCEZ T; VERHOFSTEDE C; RIMLAND D; SCHINAZI RF; ROSSAU R
      LINE PROBE ASSAY FOR RAPID DETECTION OF DRUG-SELECTED MUTATIONS IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE GENE

      Antimicrobial agents and chemotherapy
    91. SHI CF; MELLORS JW
      A RECOMBINANT RETROVIRAL SYSTEM FOR RAPID IN-VIVO ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUSCEPTIBILITY TO REVERSE-TRANSCRIPTASE INHIBITORS

      Antimicrobial agents and chemotherapy
    92. BROWN AJL
      ANALYSIS OF HIV-1 ENV GENE-SEQUENCES REVEALS EVIDENCE FOR A LOW EFFECTIVE NUMBER IN THE VIRAL POPULATION

      Proceedings of the National Academy of Sciences of the United Statesof America
    93. GOMEZCANO M; SORIANO V
      RESISTANCE TO ANTIRETROVIRAL DRUGS

      Medicina Clinica
    94. SHARMA PL; CRUMPACKER CS
      ATTENUATED REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH A DIDANOSINE-SELECTED REVERSE-TRANSCRIPTASE MUTATION

      Journal of virology
    95. NOWAK MA; BONHOEFFER S; SHAW GM; MAY RM
      ANTIVIRAL DRUG-TREATMENT - DYNAMICS OF RESISTANCE IN FREE VIRUS AND INFECTED CELL-POPULATIONS

      Journal of theoretical biology
    96. GOMEZCANO M; VILLALBA N; MAS A; HOLGUIN A; SORIANO V
      ANTIRETROVIRAL THERAPY AND RESISTANCE

      Revista Clinica Espanola
    97. MACDONALD L; KAZANJIAN P
      ANTIRETROVIRAL THERAPY IN HIV-INFECTION - AN UPDATE

      Formulary
    98. UNAL A; LORENZO E; BROWN M; SMITH L; MATSUURA S; SCOTT G; SCOTT W
      REVERSE-TRANSCRIPTASE MUTATIONS IN HIV-1-INFECTED CHILDREN TREATED WITH ZIDOVUDINE

      Journal of acquired immune deficiency syndromes and human retrovirology
    99. TAYLOR DL; AHMED SP; BRENNAN TM; NAVE JF; CASARA P; TYMS AS
      ANTI-HIV ACTIVITY OF MDL-74968, A NOVEL ACYCLONUCLEOTIDE DERIVATIVE OF GUANINE - DRUG-RESISTANCE AND DRUG-COMBINATION EFFECTS IN-VITRO

      Antiviral chemistry & chemotherapy
    100. VANDERENDE ME; SCHUTTEN M; LY TD; GRUTERS RA; OSTERHAUS ADME
      HIV-2 INFECTION IN 12 EUROPEAN RESIDENTS - VIRUS CHARACTERISTICS AND DISEASE PROGRESSION

      AIDS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 03:01:30